|
|
Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or take-home use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements. (1) Any patient…
Title 42–Public Health CHAPTER I–PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 8–CERTIFICATION OF OPIOID TREATMENT PROGRAMS Subpart A–Accreditation Sec. 8.1 Scope. 8.2 Definitions. 8.3 Application for approval as an accreditation body. 8.4 Accreditation body responsibilities. 8.5 Periodic evaluation of accreditation bodies. 8.6 Withdrawal of approval of accreditation bodies. Subpart B–Certification and Treatment Standards 8.11 Opioid treatment program certification. 8.12 Federal…
Dr Andrew Byrne, Medical Practitioner, Drug and Alcohol New South Wales, Australia Email – [email protected] September 23, 2003 This study randomised consenting heroin dependent subjects to receive one month’s treatment with (i) buprenorphine, (ii) buprenorphine/naloxone or (iii) placebo. For a further 11 months, surviving (sic) patients were followed in an open-label manner for primary outcome…
Membership Application Name: _______________________________________________________ Mr. ___ Ms. ___ Dr. ___ Organization: __________________________________________________________________________ Title: _____________________________________________ Degree(s): ________________________ Address: _____________________________________________________________________________ Address: _____________________________________________________________________________ City: __________________________________ State: ____________ Postal Code: _____________ Email: ______________________________________ Country: ________________________________ Home Phone: (____)___________________________ Work Phone: (____)_______________________ Alternate Phone: (____)________________________ Fax: (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail) Yes _____ No _____ Types of Membership $_______ Individual Membership Dues: $25 a…
Welcome to The President’s Office and to the National Alliance for Medication Assisted Recovery or NAMA Recovery. NAMA Recovery has gone through some significant changes in the past few years. We are proud of the MARS Project the first project of its kind that provides recovery services to patients receiving Medication Assisted Treatment (MAT). As…
NAMA-R NorthEast Recovery Serving the New England Region Massachusetts, Maine, Rhode Island Connecticuit, New Hampshire and Vermont Welcome to Our Web Site! This website is for all Patients in Medication Assisted Treatment. NAMA-R NorthEast Recovery Includes Program Staff and Healthcare Professionals. We Believe That We Have A Lot To Offer Each Other. The National Alliance…